# OTCQB

Type: exchange

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/otcqb
Canonical HTML page: https://getbiobrief.com/entity/otcqb

## Timeline

- **2026-10-26**: Share Hold Period Expires — Four-month-and-one-day hold period ends, allowing newly issued shares to be freely traded, subject to securities laws.
- **2026-06-25**: Anticipated Settlement Date — Settlement expected to close, with 625,000 shares issued and accrued interest paid in cash.
- **2026-06-18**: Debt-for-Equity Agreements Signed — DIAGNOS signs agreements with two lenders to settle C$125,000 in demand loans via equity issuance.

## Recent coverage (1 stories)

### DIAGNOS Converts C$125K Debt into 625K Shares at C$0.20 to Secure AI Diagnostic Pipeline
2026-06-21 00:11:46 · Sentiment: Neutral · Impact: 5/10 · Sources: 4

Biotech company DIAGNOS executes a small debt-for-equity swap, preserving liquidity to sustain its AI-based early detection platform for critical eye conditions. The move reflects the tight capital environment for early-stage diagnostic innovators.
Full story: https://getbiobrief.com/story/diagnos-debt-equity-biotech-cash

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.